Companies / Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

Nasdaq: CRNXCIK 1658247SAN DIEGO, CAcrinetics.com ↗

Financials · FY2025

Revenue$7.70M
Net income$-465.32M
Total debt—
Cash$55.50M
Diluted EPS$-4.95
Shares outstanding106.1M

Ownership

106.1M shares outstanding · as of Jul 22, 2026
0.48%Insiders
Ownership
Insiders0.48%513,597
10%+ / strategic1.36%1,439,891
Institutions95.82%101,630,306
Public float2.34%2,481,435

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Struthers Richard ScottCEOFormerPresident & CEO · Director
0.38%404,778
Betz Stephen F.Chief Scientific Officer
0.13%137,101
Wierenga WendellDirector
0.12%122,071
Knight Jeff E.Chief Operating Officer
0.11%112,018
Schilke TobinChief Financial Officer
0.07%78,121
Kalofonos IsabelFormerChief Commercial Officer
0.03%34,834
Fust Matthew KDirector
0.03%28,761
Bedrosian Camille LDirector
0.02%22,225
Vivaldi Coelho RogerioFormerDirector
0.02%16,300
Okey StephanieDirector
0.01%13,300

Institutional holders 250

View all →
HolderValue% of shares
Fmr LLC$665.38M13.48%
Vanguard Group Inc$425.26M8.61%
Wellington Management Group LLP$374.16M7.58%
BlackRock, Inc.$365.18M9.20%
Farallon Capital Management LLC$322.74M6.54%
Driehaus Capital Management LLC$297.35M6.02%
EcoR1 Capital, LLC$199.61M4.04%
Janus Henderson Group PLC$164.23M4.26%
Point72 Asset Management, L.P.$108.79M2.20%
Paradigm BioCapital Advisors LP$102.91M2.08%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q3 2025
as of
Farallon Capital Management LLC
13F manager
NewCommon stock$240.32M+5.8M
5,770,098
5.44% of shares
high
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon stock$66.25M+1.8M
+22.16%
9,758,938
9.20% of shares
high
Q4 2025
as of
Farallon Capital Management LLC
13F manager
AddCommon stock$54.14M+1.2M
+20.16%
6,933,098
6.54% of shares
high
Q1 2026
as of
Baker Bros. Advisors LP
13F manager
AddCommon stock$25.52M+703K
+42.61%
2,351,465
2.22% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon stock$24.85M+684K
684,108
0.64% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
AddCommon stock$19.76M+528K
+24.43%
2,689,350
2.54% of shares
medium
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
ExitCommon stock$-10.86M-233K
-100.00%
0
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon stock$9.32M+200K
+33.32%
801,314
0.76% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Fmr LLCPassive13G/A—1,439,891—
Vanguard Group IncPassive13G/A—0—
Farallon Capital Partners, L.P.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CRNX——22663K107—